Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | TYR | P14679 | 1/20 | 0.33 |
| ▸ | NR3C2 | P08235 | 5/20 | 0.32 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.32 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.31 |
| ▸ | PKLR | P30613 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23116950 | 0.81 | KDM4E (0.41) | KDM4EGAAPKMMEN1NPC1 | |
| SCHEMBL22290502 | 0.81 | KDM4E (0.37) | KDM4EGAAPKMMEN1NPC1 | |
| SCHEMBL29473475 | 0.81 | MAOB (0.39) | PKMNPC1RAB9ASMN1; SMN2TYR | |
| SCHEMBL1429325 | 0.81 | KDM4E (0.44) | KDM4EGAAPKMMEN1NPC1 | |
| SCHEMBL1350215 | 0.81 | MAOB (0.39) | PKMNPC1RAB9ASMN1; SMN2TYR | |
| SCHEMBL4744769 | 0.76 | — | — | |
| SCHEMBL1265859 | 0.72 | NOTUM (0.47) | KDM4EGAAPKMMEN1NPC1 | |
| SCHEMBL31064343 | 0.71 | PRKCG (0.38) | — | |
| SCHEMBL19312655 | 0.70 | KDM4E (0.39) | KDM4EGAAPKMMEN1NPC1 | |
| SCHEMBL1892290 | 0.69 | FABP6 (0.54) | KDM4EGAAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113584885-B | Antibacterial polyester fabric and preparation method thereof | 上海沙驰服饰有限公司 | 2022-11-25 | — | — | CN | claimed |
| US-20230348441-A1 | BICYCLIC COMPOUND THAT ACTS AS CRBN PROTEIN REGULATOR | MEDSHINE DISCOVERY INC. (CN) | 2023-11-02 | — | — | US | disclosed |
| CN-113584885-B | Antibacterial polyester fabric and preparation method thereof | 上海沙驰服饰有限公司 | 2022-11-25 | — | — | CN | disclosed |
| CN-113584885-A | Antibacterial polyester fabric and preparation method thereof | 上海沙驰服饰有限公司 | 2021-11-02 | — | — | CN | disclosed |
| WO-2008084067-A2 | PHARMACEUTICALLY ACTIVE DIHYDROBENZOFURANE-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES | NYCOMED GMBH (DE) | 2008-07-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230348441-A1 | BICYCLIC COMPOUND THAT ACTS AS CRBN PROTEIN REGULATOR | CRBN, CRKL, NCOR1 | KDM4E 2887/4885GAA 4139/4885PKM 3422/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.